ストックスクリーナーアプリを入手
6.21
1.11%
-0.09
アフターアワーズ：
6.28
0.07
+1.13%
前日終値:
$6.30
開ける：
$6.31
24時間の取引高:
101.54K
Relative Volume:
0.99
時価総額：
$77.98M
収益：
$4.28M
当期純損益:
$-7.28M
株価収益率:
-7.6234
EPS:
-0.8146
ネットキャッシュフロー:
$-6.17M
1週間 パフォーマンス:
-9.32%
1か月 パフォーマンス:
-7.70%
6か月 パフォーマンス:
+15.58%
1年 パフォーマンス:
+158.51%
1日の値動き範囲:
$6.17
$6.4605
1週間の範囲:
$5.50
$6.7823
52週間の値動き範囲:
$2.21
$9.33
Neuraxis Inc Stock (NRXS) Company Profile
名前
Neuraxis Inc
セクター
電話
(812) 689-0791
住所
11550 North Meridian Street, Suite 325, Carmel
Compare NRXS vs VRTX, REGN, ARGX, RVMD, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NRXS
Neuraxis Inc
|
6.21 | 79.11M | 4.28M | -7.28M | -6.17M | -0.8146 |
VRTX
Vertex Pharmaceuticals Inc
|
515.57 | 128.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
805.86 | 82.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
986.80 | 53.26B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
211.94 | 43.66B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
362.66 | 39.31B | 5.76B | 514.49M | 1.10B | 4.4813 |
Neuraxis Inc (NRXS) 最新ニュース
NRXS Stock Dips Post Q2 Earnings Despite Revenue Surge, Gross Margin Up - NewsBreak: Local News & Alerts
NeurAxis revenues up 116% to USD 1.9M in Q2 2026 - Medical Buyer
NeurAxis, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
NeurAxis (NRXS) Q2 2026 Earnings Call Transcript - The Globe and Mail
Could NeurAxis (NASDAQ:NRXS) Reshape Nasdaq Composite Focus? - Kalkine Media
Transcript : NeurAxis, Inc., Q2 2026 Earnings Call, Aug 11, 2026 - marketscreener.com
NeurAxis (NASDAQ:NRXS): What Could Today’s Update Reveal About Pediatric Therapy Adoption And Reimbursement? - kalkinemedia.com
NRXS: Q2 revenue up 116% YoY, gross margin at 85.9%, with payer coverage and VA expansion driving growth - TradingView
Earnings call transcript: NeurAxis falls on Q2 2026 EPS miss despite 116% revenue growth - Investing.com
NeurAxis reports 116% revenue growth in second quarter 2026 - Investing.com
NeurAxis Reports Record Second Quarter 2026 Financial Results Driven by 116% Year Over Year Revenue Growth - The Manila Times
NRXS: Q2 2026 revenue surged 116% year-over-year, with gross margin up to 85.9% and strong cash position - TradingView
NeurAxis (NYSE American: NRXS) doubles sales yet warns on going concern - Stock Titan
Earnings To Watch: Neuraxis Inc (NRXS) Q2 2026 -- GF Value Sees 55% Downside - Yahoo Finance
NeurAxis, Inc. (NRXS) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
NeurAxis宣佈爲IB-Stim PENFS療法增加美國中大西洋地區的覆蓋範圍，將服務擴展至超過500,000人 - Moomoo
Neuraxis Expands Payer Coverage for Percutaneous Electrical Nerve Field Stimulation and Ib-Stim Treatment - marketscreener.com
NeurAxis expands insurance coverage for its IB-Stim neuromodulation device, adding 500,000 covered lives. - Pluang
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
NRXS|Neuraxis Inc|Price:6.735|Chg%:+0.485 - TradingKey
Neuraxis Inc (NRXS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
NeurAxis to Host Second Quarter 2026 Results and Business Update Call on Tuesday, August 11, 2026 - The Manila Times
NeurAxis, Inc. to Report Second Quarter 2026 Financial Results on August 11 and Host Conference Call - Quiver Quantitative
Neuraxis Inc (NRXS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Neuraxis Inc (NRXS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Neuraxis Inc (NRXS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Neuraxis Inc (NRXS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
NRXS|Neuraxis Inc|Price:6.800| - TradingKey
Neuraxis Inc (NRXS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TradingKey - TradingKey
Neuraxis, Inc. Revenue Breakdown – AMEX:NRXS - TradingView
Form S-3 Neuraxis Inc For: 24 July By Investing.com - Investing.com South Africa
Neuraxis Inc. (NRXS) Q1 2026 Earnings: EPS Beat Despite Negative Bottom Line, Stock SlidesEarnings Season Preview - DonanımHaber
Neuraxis, Inc. Files Form 8-K with SEC: Company Details, Address, and Stock Listing on NYSE American - Minichart
NeurAxis Declares Q2 Stock Dividend on Series B - TipRanks
Neuraxis declares stock dividend for Series B preferred, ~80,463 common shares to be issued - TradingView
NRXSNeuraxis Inc Latest SEC Filings - Finviz
Neuraxis Inc. (NRXS) Holds Steady Near Resistance Amid Low Volatility SessionPost-Earnings Moves - dars.gov.et
Neuraxis Inc. (NRXS) Hovers Near Key Support Level After Modest DeclineMACD Signal Stocks - dars.gov.et
NeurAxis, Inc.(NYSEAM: NRXS) added to Russell Microcap Growth Benchmark Index - marketscreener.com
NeurAxis, Inc.(NYSEAM: NRXS) added to Russell 3000E Growth Benchmark - marketscreener.com
NeurAxis, Inc.(NYSEAM: NRXS) added to Russell Microcap Index - marketscreener.com
NeurAxis, Inc.(NYSEAM: NRXS) added to Russell 3000E Index - marketscreener.com
Price to sales forward of Neuraxis, Inc. – AMEX:NRXS - TradingView
Price to sales forward of Neuraxis, Inc. – BOATS:NRXS - TradingView
Enterprise value to EBIT forward of Neuraxis, Inc. – AMEX:NRXS - TradingView
Enterprise value to EBIT forward of Neuraxis, Inc. – BOATS:NRXS - TradingView
Price to book forward of Neuraxis, Inc. – AMEX:NRXS - TradingView
Enterprise value to revenue forward of Neuraxis, Inc. – AMEX:NRXS - TradingView
Price to earnings forward of Neuraxis, Inc. – BOATS:NRXS - TradingView
Enterprise value to EBITDA forward of Neuraxis, Inc. – BOATS:NRXS - TradingView
Neuraxis Inc (NRXS) 財務データ
収益
当期純利益
現金流量
EPS
2.20%
0.07%
大文字化:
|
ボリューム (24 時間):